Ikena Oncology Inc IKNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
1.40quote price arrow up+0.06 (+4.87%)
Volume
141
52 week range
1.02 - 7.38
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.40
  • 52 Week High7.38
  • 52 Week High Date06/16/23
  • 52 Week Low1.02
  • 52 Week Low Date11/09/23

Key Stats

  • Market Cap67.561M
  • Shares Out48.26M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.39
  • YTD % Change-32.23

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.40
  • 52 Week High7.38
  • 52 Week High Date06/16/23
  • 52 Week Low1.02
  • 52 Week Low Date11/09/23
  • Market Cap67.561M
  • Shares Out48.26M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.39
  • YTD % Change-32.23

RATIOS/PROFITABILITY

  • EPS (TTM)-1.58
  • P/E (TTM)-0.89
  • Fwd P/E (NTM)-0.91
  • EBITDA (TTM)-74.537M
  • ROE (TTM)-48.28%
  • Revenue (TTM)3.848M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,821.54%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ikena Oncology Inc

 

Content From Our Affiliates

Profile

MORE
Ikena Oncology, Inc. is a targeted oncology company. The Company is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. The Company's lead targeted oncology program, IK-930, is a transcriptional enhanced associate domain 1 (TEAD1) selective Hippo pathway inhibitor, a known tumor suppressor pathway that also drives resistance to multiple targeted...
Owen Hughes Jr.
Independent Chairman of the Board
Mark Manfredi Ph.D.
President, Chief Executive Officer, Director
Jotin Marango
Chief Financial Officer, Head of Corporate Development
Address
50 Northern Ave.
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
BLRX
BioLine RX Ltd
0.6419+0.025+4.0441%
HCWB
HCW Biologics Inc
1.10-0.06-5.17%
DYAI
Dyadic International Inc
1.66+0.09+5.73%
QTTB
Q32 Bio Inc
31.00+1.60+5.44%
KZR
Kezar Life Sciences Inc
0.768-0.0043-0.5568%